Checkpoint Therapeutics, Inc.

NasdaqCM:CKPT Stok Raporu

Piyasa değeri: US$100.8m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Checkpoint Therapeutics Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

James Oliviero

İcra Kurulu Başkanı

US$1.6m

Toplam tazminat

CEO maaş yüzdesi38.7%
CEO görev süresi9yrs
CEO sahipliği4.3%
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresi6yrs

Son yönetim güncellemeleri

Recent updates

We're A Little Worried About Checkpoint Therapeutics' (NASDAQ:CKPT) Cash Burn Rate

Sep 20
We're A Little Worried About Checkpoint Therapeutics' (NASDAQ:CKPT) Cash Burn Rate

Checkpoint: Strong Data, But Comes With Risks

Sep 08

Checkpoint Therapeutics GAAP EPS of -$0.16 in-line, revenue of $0.02M beats by $0.01M

Aug 12

Is Checkpoint Therapeutics (NASDAQ:CKPT) In A Good Position To Deliver On Growth Plans?

May 18
Is Checkpoint Therapeutics (NASDAQ:CKPT) In A Good Position To Deliver On Growth Plans?

Checkpoint Therapeutics: Potential Upside Based On Marketing Application Submissions

Apr 18

Companies Like Checkpoint Therapeutics (NASDAQ:CKPT) Are In A Position To Invest In Growth

Feb 15
Companies Like Checkpoint Therapeutics (NASDAQ:CKPT) Are In A Position To Invest In Growth

Checkpoint Therapeutics: Another Buying Opportunity Following Cosibelimab's Impressive Topline Results

Jan 28

Checkpoint Therapeutics: Pullback Provides Opportunity To Add Ahead Of Cosibelimab's Data Readout

Nov 26

Checkpoint Therapeutics (NASDAQ:CKPT) Is In A Good Position To Deliver On Growth Plans

Oct 30
Checkpoint Therapeutics (NASDAQ:CKPT) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Checkpoint Therapeutics' (NASDAQ:CKPT) Cash Burn Rate

Jul 17
We're Not Very Worried About Checkpoint Therapeutics' (NASDAQ:CKPT) Cash Burn Rate

Checkpoint Therapeutics: Amassing A Position Ahead Of Cosibelimab Data

Jul 14

Checkpoint Therapeutics (CKPT) Investor Presentation - Slideshow

Jun 21

Checkpoint surges 24% on B. Riley buy initiation, 567% upside potential

Jun 09

It's Unlikely That Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) CEO Will See A Huge Pay Rise This Year

Jun 02
It's Unlikely That Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) CEO Will See A Huge Pay Rise This Year

The Checkpoint Therapeutics (NASDAQ:CKPT) Share Price Is Up 141% And Shareholders Are Boasting About It

Mar 11
The Checkpoint Therapeutics (NASDAQ:CKPT) Share Price Is Up 141% And Shareholders Are Boasting About It

Have Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Insiders Been Selling Their Stock?

Feb 06
Have Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Insiders Been Selling Their Stock?

Do Institutions Own Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Shares?

Jan 27
Do Institutions Own Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Shares?

CEO Tazminat Analizi

James Oliviero'un ücretlendirmesi Checkpoint Therapeutics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$42m

Mar 31 2024n/an/a

-US$52m

Dec 31 2023US$2mUS$636k

-US$52m

Sep 30 2023n/an/a

-US$54m

Jun 30 2023n/an/a

-US$59m

Mar 31 2023n/an/a

-US$56m

Dec 31 2022US$2mUS$594k

-US$63m

Sep 30 2022n/an/a

-US$71m

Jun 30 2022n/an/a

-US$72m

Mar 31 2022n/an/a

-US$67m

Dec 31 2021US$2mUS$540k

-US$57m

Sep 30 2021n/an/a

-US$37m

Jun 30 2021n/an/a

-US$31m

Mar 31 2021n/an/a

-US$26m

Dec 31 2020US$2mUS$515k

-US$23m

Sep 30 2020n/an/a

-US$22m

Jun 30 2020n/an/a

-US$22m

Mar 31 2020n/an/a

-US$22m

Dec 31 2019US$2mUS$480k

-US$25m

Sep 30 2019n/an/a

-US$28m

Jun 30 2019n/an/a

-US$32m

Mar 31 2019n/an/a

-US$33m

Dec 31 2018US$2mUS$450k

-US$36m

Sep 30 2018n/an/a

-US$31m

Jun 30 2018n/an/a

-US$27m

Mar 31 2018n/an/a

-US$27m

Dec 31 2017US$645kUS$430k

-US$23m

Tazminat ve Piyasa: James 'nin toplam tazminatı ($USD 1.64M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 677.23K ).

Tazminat ve Kazançlar: James 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

James Oliviero (48 yo)

9yrs

Görev süresi

US$1,641,591

Tazminat

Mr. James F. Oliviero, III, CFA has been the Chief Executive Officer and President of Checkpoint Therapeutics, Inc. since October 16, 2015 and also has been its Director since October 15, 2018. Mr. Olivier...

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
James Oliviero
President6yrsUS$1.64m4.31%
$ 4.3m
Michael Weiss
Chairman of the Board9.6yrsUS$110.00k0.25%
$ 251.3k
Lindsay Rosenwald
Non-Executive Director9.9yrsUS$100.00k0.29%
$ 296.1k
Wayne Marasco
Chairman of Scientific Advisory Board9.6yrsVeri yokVeri yok
Roy Steven Herbst
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Neil Herskowitz
Independent Director9.2yrsUS$110.00k0.26%
$ 262.5k
Christian Béchon
Independent Director6yrsUS$100.00k0.25%
$ 256.5k
Barry Salzman
Independent Director8.8yrsUS$100.00k0.26%
$ 262.5k
Bruce Johnson
Member of Scientific Advisory Board3.6yrsVeri yokVeri yok
F. Hodi
Member of Scientific Advisory Board3.6yrsVeri yokVeri yok
David Miller
Member of Scientific Advisory Board3.6yrsVeri yokVeri yok
Emily Ruiz
Member of Scientific Advisory Board3.6yrsVeri yokVeri yok

6.0yrs

Ortalama Görev Süresi

63.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CKPT 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6 yıldır).